|
|
 |
[2025/06/11] |
 |
|
 |
 |

±¹³»Æ¯Çã 5°Ç µî·Ï ~ |
 |
|
|
¹ß¸íÀÇ ¸íĪ: Ç¥Àû ´Ü¹éÁú¿¡ ÀÇÇØ °ú¹ßÇöµÇ´Â Å»À¯ºñÄûÆ¾È È¿¼ÒÀÇ °ËÃâ¹æ¹ý
Ãâ¿øÀÏ: 2024.09.10
µî·ÏÀÏ: 2025.06.04
Ãâ¿ø¹øÈ£: 10-2024-0122809
µî·Ï¹øÈ£: 10-2818565
¹ß¸íÀÇ ¸íĪ: Ç¥Àû ´Ü¹éÁú¿¡ ÀÇÇØ Àú¹ßÇöµÇ´Â Å»À¯ºñÄûÆ¾È È¿¼ÒÀÇ °ËÃâ¹æ¹ý
Ãâ¿øÀÏ: 2024.09.10
µî·ÏÀÏ: 2025.06.04
Ãâ¿ø¹øÈ£: 10-2024-0122812
µî·Ï¹øÈ£: 10-2818568
¹ß¸íÀÇ ¸íĪ: ´ëÀå¾Ï ¼¼Æ÷¿¡¼ Ç¥Àû ´Ü¹éÁú¿¡ ÀÇÇØ °ú¹ßÇö ¶Ç´Â Àú¹ßÇöµÇ´Â Å»À¯ºñÄûÆ¾È È¿¼ÒÀÇ °ËÃâ¹æ¹ý
Ãâ¿øÀÏ: 2024.09.10
µî·ÏÀÏ: 2025.06.04
Ãâ¿ø¹øÈ£: 10-2024-0122822
µî·Ï¹øÈ£: 10-2818569
¹ß¸íÀÇ ¸íĪ: ´ëÀå¾Ï ¼¼Æ÷¿¡¼ Ç¥Àû ´Ü¹éÁú¿¡ ÀÇÇØ Àú¹ßÇöµÇ´Â Å»À¯ºñÄûÆ¾È È¿¼ÒÀÇ °ËÃâ¹æ¹ý
Ãâ¿øÀÏ: 2024.09.10
µî·ÏÀÏ: 2025.06.04
Ãâ¿ø¹øÈ£: 10-2024-0122836
µî·Ï¹øÈ£: 10-2818573
¹ß¸íÀÇ ¸íĪ: Ç¥Àû ´Ü¹éÁú¿¡ ÀÇÇØ °ú¹ßÇöµÇ´Â Å»À¯ºñÄûÆ¾È È¿¼ÒÀÇ °ËÃâÀ» À§ÇÑ ´ÙÁß ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ¿ë ÇÁ¶óÀÌ¸Ó ¼¼Æ®
Ãâ¿øÀÏ: 2024.09.10
µî·ÏÀÏ: 2025.06.04
Ãâ¿ø¹øÈ£: 10-2024-0122838
µî·Ï¹øÈ£: 10-2818578 |
|
|
|
|
 |
[2025/06/03] |
 |
|
 |
 |

Manuscript Accepted !! |
 |
|
|
³í¹®Á¦¸ñ: Regulation of Botulinum neurotoxin half-life through the ubiquitin-proteasome system
Àú³Î: Molecular Medicine Reports (2023 Impact factor: 3.4) |
|
|
|
|
 |
[2025/03/12] |
 |
|
 |
 |

ºê¸¯ÀÇ ÇѺû»ç ³í¹® µîÀç |
 |
|
|
|
|
 |
[2025/03/04] |
 |
|
 |
 |

Manuscript Accepted !! |
 |
|
|
³í¹®Á¦¸ñ: Unraveling the Role of Deubiquitinating Enzymes on Cisplatin Resistance in Several Cancers
Àú³Î: BBA - Reviews on Cancer (2023 Impact factor: 9.7) |
|
|
|
|
 |
[2025/02/27] |
 |
|
 |
 |

¹Ì±¹ ƯÇãµî·Ï °áÁ¤ !! |
 |
|
|
ƯÇã¸í: ANALYSIS METHOD AND KIT FOR DIAGNOSIS OF UROLITHIASIS (¿ä·Î°á¼® Áø´ÜÀ» À§ÇÑ ºÐ¼®¹æ¹ý ¹× ŰƮ)
U.S. Patent Application No.: 17/310,163 |
|
|
|
|
|